Lopinavir/r monotherapy used as second-line therapy in resource-limited settings
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Conference reports
Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
1 August 2011. Related: Conference reports, Pregnancy, Paediatric care.
Lopinavir/ritonavir oral solution toxicity in neonates
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Paediatric antiretroviral pipeline: darunavir and raltegravir
1 August 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART
1 August 2011. Related: Conference reports, PK and drug interactions, TB coinfection.
Initiation of ART during breastfeeding can induce multidrug resistance in infants
1 August 2011. Related: Conference reports, Pregnancy.
First Workshop on Nanomedicine for Infectious Diseases of Poverty, 27-31 March 2011, Magaliesberg, South Africa
10 May 2011. Related: Conference reports.
17th Annual Conference of the British HIV Association (BHIVA), 6-8 April 2011, Bournemouth
1 May 2011. Related: Conference reports.
Atazanavir in pregnancy: 155 cases in London clinics
1 May 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Co-morbidity and late presentation – findings from an over 50s cohort
1 May 2011. Related: Conference reports.
Health outcomes for young adults with perinatally acquired HIV infection following transfer to adult services
1 May 2011. Related: Conference reports, Paediatric care.
The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals
1 May 2011. Related: Conference reports.
Frequency and characteristics of long-term non-progressors and HIV controllers in the Chelsea and Westminster cohort
1 May 2011. Related: Conference reports.
Cerebral function in perinatally HIV infected young people and HIV uninfected sibling controls
1 May 2011. Related: Conference reports.
An audit of HIV care provision for Immigration Removal Centre patients
1 May 2011. Related: Conference reports, Treatment access.
12th International Workshop on Clinical Pharmacology of HIV Therapy, 13-15 April 2011, Miami
1 May 2011. Related: Conference reports.
Quad reduces levels of oral contraceptives
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Elvitegravir/cobicistat and acid reducing agents
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Lopinavir/r reduces levels of rifabutin
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Cobicistat has little impact on CYP2D6 and CYP2B6
1 May 2011. Related: Conference reports, Antiretrovirals.
Atazanavir levels indicate need for higher dose during pregnancy
1 May 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Etravirine lowers levels of maraviroc given at 300 or 600 mg twice daily
1 May 2011. Related: Conference reports, Antiretrovirals.
Once-daily 150-mg maraviroc explored in people taking atazanavir/ritonavir
1 May 2011. Related: Conference reports, Antiretrovirals.
Lopinavir troughs lower in children on once-daily dose with efavirenz
1 May 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Dose optimisation: 50 mg ritonavir-boosting, 3TC dosing and raltegravir once-daily
1 May 2011. Related: Conference reports, Antiretrovirals, Treatment strategies.
46th European Association for the Study of the Liver (EASL), 30 March-3 April 2011, Berlin, Germany
1 May 2011. Related: Conference reports.
Rapid report: state of HCV policy, treatment, access
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 May 2011. Related: Conference reports.
When to start ART in patients co-infected with TB: results from two trials presented at CROI
1 May 2011. Related: Conference reports, Antiretrovirals, TB coinfection.
Inflammation and intervention: how does HIV cause AIDS and how does it cause disease despite ART
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 April 2011. Related: Conference reports.
New antiretrovirals: dolutegravir, entry inhibitor (BMS-663068) and tenofovir pro-drug (GS-7340)
1 April 2011. Related: Conference reports, Antiretrovirals.
Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study
1 April 2011. Related: Conference reports, Antiretrovirals.
Antiretroviral prevention: oral PrEP, gels and treatment studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Further efficacy analyses from the iPrEx study
1 April 2011. Related: Conference reports, Antiretrovirals.
Topical gels as PEP and PrEP: animal and human studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Maternal risk following short course HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Pre-term delivery and HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
HAART more effective than AZT monotherapy in the Botswana PMTCT programme
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Lopinavir/r monotherapy for PMTCT
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland
1 April 2011. Related: Conference reports, Pregnancy.
Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi
1 April 2011. Related: Conference reports, Pregnancy.
Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women
1 April 2011. Related: Conference reports, Pregnancy.
First results from telaprevir in HIV/HCV coinfection
1 April 2011. Related: Conference reports, Antiretrovirals, Hepatitis coinfection.
HCV reinfection rates in HIV-positive gay men
1 April 2011. Related: Conference reports.
1st International Workshop on HIV and Women, 10-11 January 2011, Washington
1 February 2011. Related: Conference reports.
Lopinavir/ritonavir: women versus men
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Quality of life in the GRACE study
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Antiretroviral pharmacokinetics in women with undetectable viral load
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Weight, diabetes, metabolic complications.
The impact of antiretroviral treatment on fertility intentions in South Africa
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
41st Union World Conference on Lung Health, 11-15 November 2010, Berlin
1 February 2011. Related: Conference reports, TB coinfection.
Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB
1 February 2011. Related: Conference reports, TB coinfection.
Xpert MTB-RIF validation study from Tanzania
1 February 2011. Related: Conference reports, TB coinfection.
GeneXpert demonstrates good sensitivity and specificity but at high cost
1 February 2011. Related: Conference reports, TB coinfection.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 February 2011. Related: Conference reports.
Intestinal microflora and low grade metabolic inflammation
1 February 2011. Related: Conference reports, Weight, diabetes, metabolic complications.
Complex connections between bone and fat metabolism
1 February 2011. Related: Conference reports, PK and drug interactions, Weight, diabetes, metabolic complications.
10th International Congress on Drug Therapy in HIV Infection, 7-11 November 2010, Glasgow
1 December 2010. Related: Conference reports.
Virological findings from the SARA trial ofboosted protease inhibitor monotherapy
1 December 2010. Related: Conference reports, Antiretrovirals, Treatment access, Virology.
Nevirapine exposure was not associated with hypersensitivity in patients from Malawi
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Estimating the number of people in a country or region with HIV who are undiagnosed and in need of ART
1 December 2010. Related: Conference reports, Antiretrovirals.
Highpreterm delivery rates associated with initiation of HAART during pregnancy at a London clinic
1 December 2010. Related: Conference reports, Pregnancy.
Minority M184V variants detected in women after receiving 3TC/FTC and LPV/r-containing regimens in pregnancy
1 December 2010. Related: Conference reports, Pregnancy, Drug resistance.
The Antiretroviral Pregnancy Registry reports no increased rate of birth defects with atazanavir exposure
1 December 2010. Related: Conference reports, Pregnancy.